Skip to main content
. 2017 Jan 10;35(4):451–462. doi: 10.1007/s10637-016-0416-x

Fig. 2.

Fig. 2

Plasma concentration–time profiles of AZD4547 after a single dosing and b multiple dosing. Geometric mean plasma concentrations are shown against time for the dosing levels 40 mg bid, 80 mg bid (combined from cohorts dosed at the 80 mg bid level across both Parts A and B), 120 mg bid, and 160 mg qd